Biden administration invests $48M in AI/ML platform to identify rare disease drugs

The Biden ad­min­is­tra­tion is dol­ing out $48 mil­lion to a non­prof­it that wants to use ma­chine learn­ing and ar­ti­fi­cial in­tel­li­gence to iden­ti­fy po­ten­tial rare dis­ease treat­ments and score how well they could work for cer­tain dis­eases, of­fi­cials an­nounced this week.

The Ad­vanced Re­search Projects Agency for Health (ARPA-H) pro­vid­ed the grant to the non­prof­it Every Cure, which aims to find treat­ments for rare dis­eases by re­pur­pos­ing ex­ist­ing med­ica­tions. The project, dubbed ML/AI-Aid­ed Ther­a­peu­tic Re­pur­pos­ing In eX­tend­ed us­es, or MA­TRIX, will be fund­ed over three years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.